14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
ESTA vs RBOT.WS: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
ESTA Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 7–1 Matrix Metrics)
ESTA Overall Winner
6-Pillar Tally: ESTA 6 – 0 RBOT.WS
Matrix Metrics: ESTA 7 – 1 RBOT.WS
As of Nov 20, 2026, Establishment Labs Holdings Inc. (ESTA) is the stronger overall head-to-head candidate over Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of (RBOT.WS) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ESTA carries a Unified Composite Score of 35.7/100 (SELL) at $69.14 (N/M Forward P/E, -6.6% operating margin), whereas RBOT.WS carries 50.1/100 (HOLD) at $0.01 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While RBOT.WS currently prints a higher short-term Unified Composite Score (50.1/100 HOLD vs. ESTA 35.7/100 SELL), ESTA captures the overall institutional head-to-head verdict (7–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-6.6% vs. N/A operating margin) and revenue trajectory (+33.9% vs. N/A YoY).
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ESTA vs RBOT.WS. Trailing 12-month operating profitability (ESTA -6.6% vs RBOT.WS N/A) and valuation multiples (ESTA N/M vs RBOT.WS N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Orthopedic, Prosthetic & Surgical Appliances & Supplies value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ ESTA vs RBOT.WS Key Questions & Quantitative Answers
As of Nov 20, 2026, Establishment Labs Holdings Inc. (ESTA) is the stronger overall head-to-head candidate over Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of (RBOT.WS) in the Tradestie Institutional Equity Comparison Engine, winning 7–1 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). ESTA carries a Unified Composite Score of 35.7/100 (SELL) at $69.14 (N/M Forward P/E, -6.6% operating margin), whereas RBOT.WS carries 50.1/100 (HOLD) at $0.01 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While RBOT.WS currently prints a higher short-term Unified Composite Score (50.1/100 HOLD vs. ESTA 35.7/100 SELL), ESTA captures the overall institutional head-to-head verdict (7–1 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (-6.6% vs. N/A operating margin) and revenue trajectory (+33.9% vs. N/A YoY).
ESTA leads the Growth & Scale pillar: ESTA posts +33.9% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (70.2% gross margin, -6.6% operating margin), compared with RBOT.WS at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, ESTA generates $264M in USD-normalized revenue versus N/A for RBOT.WS. In operating R&D and SG&A reinvestment, ESTA deploys 76.8% of Rev ($203M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for RBOT.WS.
ESTA screens cheaper on headline valuation multiples. ESTA trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 8.6x EV/Revenue (-8.8% FCF margin), whereas RBOT.WS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ESTA (-240.7% ROE) versus RBOT.WS (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, ESTA carries 58.9% implied volatility (5th %ile, Compressed (<25th %ile)), a 0.05x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.49β · 57% Vol realized risk). By comparison, RBOT.WS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (N/A realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00 (RBOT.WS) Research Suite
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.